Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Child-Pugh Class A”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Testing effectiveness (Phase 2)Study completedNCT03211416
What this trial is testing

Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer

Who this might be right for
Advanced Adult Hepatocellular CarcinomaChild-Pugh Class AStage III Hepatocellular Carcinoma+6 more
Roswell Park Cancer Institute 37
Early research (Phase 1)Study completedNCT05088642
What this trial is testing

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

Who this might be right for
Sever Aplastic Anaemia
Jiangsu HengRui Medicine Co., Ltd. 24
Large-scale testing (Phase 3)UnknownNCT00921531
What this trial is testing

Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 200
Early research (Phase 1)Study completedNCT02507765
What this trial is testing

Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Child-Pugh Class AChild-Pugh Class BStage IIIA Hepatocellular Carcinoma+4 more
Ohio State University Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT02115373
What this trial is testing

C-Met Second-Line Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Merck KGaA, Darmstadt, Germany 66
Testing effectiveness (Phase 2)Study completedNCT01988493
What this trial is testing

Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Merck KGaA, Darmstadt, Germany 117
Early research (Phase 1)Not Yet RecruitingNCT06994572
What this trial is testing

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Captor Therapeutics S.A. 141
Early research (Phase 1)Study completedNCT06888115
What this trial is testing

The Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Who this might be right for
Primary Biliary Cholangitis
Cascade Pharmaceuticals, Inc 24
Testing effectiveness (Phase 2)Study completedNCT03109886
What this trial is testing

Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tiziana Life Sciences LTD 31
Large-scale testing (Phase 3)Looking for participantsNCT05201404
What this trial is testing

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma 471
Early research (Phase 1)Study completedNCT02256033
What this trial is testing

Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline

Who this might be right for
Hepatic Impairment
Kyowa Kirin Co., Ltd. 20
Post-approval studies (Phase 4)Study completedNCT01846455
What this trial is testing

Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects

Who this might be right for
Hepatic FailureHepatic ImpairmentChronic Hepatitis C Infection With Hepatic Coma
Indivior Inc. 43
Testing effectiveness (Phase 2)Study completedNCT02128958
What this trial is testing

Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Can-Fite BioPharma 78
Early research (Phase 1)Ended earlyNCT04136444
What this trial is testing

A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function

Who this might be right for
Healthy Study ParticipantsImpaired Hepatic Function
UCB Biopharma S.P.R.L. 12
Large-scale testing (Phase 3)Ended earlyNCT02762266
What this trial is testing

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Who this might be right for
Child-Pugh Class AChild-Pugh Class BRecurrent Hepatocellular Carcinoma
Stanford University 13
Early research (Phase 1)Looking for participantsNCT06957756
What this trial is testing

Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 44
Testing effectiveness (Phase 2)Study completedNCT02994056
What this trial is testing

Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 32
Large-scale testing (Phase 3)Study completedNCT02201901
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 268
Testing effectiveness (Phase 2)Study completedNCT00073736
What this trial is testing

Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Ligand Pharmaceuticals 28
Early research (Phase 1)WithdrawnNCT02989870
What this trial is testing

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Who this might be right for
HepatoCellular CarcinomaUnresectable HepatoCellular CarcinomaLiver Cancer
H. Lee Moffitt Cancer Center and Research Institute
Load More Results